Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience. - Suppr | 超能文献

Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience.

作者信息

Cencini Emanuele, Fabbri Alberto, Sicuranza Anna, Santoni Adele, Bocchia Monica

机构信息

Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.

University of Siena, Siena, Italy.

出版信息

Hematol Oncol. 2019 Oct;37(4):493-495. doi: 10.1002/hon.2675. Epub 2019 Sep 11.

DOI:10.1002/hon.2675

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience.

Hematol Oncol. 2019 Oct;37(4):493-495. doi: 10.1002/hon.2675. Epub 2019 Sep 11.

2

Treatment of Hodgkin lymphoma: a 50-year perspective.霍奇金淋巴瘤的治疗：50年回顾

J Clin Oncol. 2014 Jan 20;32(3):163-8. doi: 10.1200/JCO.2013.53.1194.

3

Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.接受多柔比星、博来霉素、长春碱和达卡巴嗪治疗的人类免疫缺陷病毒感染和晚期霍奇金淋巴瘤患者的长期随访

Haematologica. 2013 Aug;98(8):e85-6. doi: 10.3324/haematol.2012.079921. Epub 2013 May 28.

4

Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.早期不良型霍奇金淋巴瘤的治疗：4周期与6周期ABVD化疗联合放疗的疗效与毒性

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):110-8. doi: 10.1016/j.ijrobp.2016.03.052. Epub 2016 Apr 13.

5

Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.基于诊断时预后和早期反应的情况，采用多柔比星/博来霉素/长春花碱/达卡巴嗪联合受累野放疗进行三或六周期风险适应性治疗霍奇金淋巴瘤：GATLA 研究结果。

Clin Lymphoma Myeloma Leuk. 2010 Jun;10(3):181-5. doi: 10.3816/CLML.2010.n.028.

6

[Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international randomized phase III HD16 trial conducted by the German Hodgkin Study Group].[正电子发射断层扫描引导下的早期预后良好型霍奇金淋巴瘤治疗：德国霍奇金淋巴瘤研究组开展的国际随机 III 期 HD16 试验的最终结果]

Strahlenther Onkol. 2020 Apr;196(4):414-415. doi: 10.1007/s00066-020-01593-0.

7

Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma.验证简化的国际预后评分（IPS-3）在晚期经典霍奇金淋巴瘤患者中的应用。

Br J Haematol. 2020 Apr;189(1):122-127. doi: 10.1111/bjh.16293. Epub 2019 Dec 10.

8

Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen.国际预后评分在接受多柔比星、博来霉素、长春碱和达卡巴嗪方案治疗的晚期人类免疫缺陷病毒感染相关霍奇金淋巴瘤中的预后价值有限。

Leuk Lymphoma. 2009 Oct;50(10):1718-20. doi: 10.1080/10428190903174359.

9

Long-term follow-up of survival in Hodgkin's lymphoma.霍奇金淋巴瘤生存情况的长期随访

N Engl J Med. 2009 Dec 10;361(24):2390-1. doi: 10.1056/NEJMc0906731.

10

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.多柔比星、博来霉素、长春花碱和达卡巴嗪联合抗逆转录病毒治疗的晚期人类免疫缺陷病毒相关性经典霍奇金淋巴瘤的预后因素：一项多机构回顾性研究。

Cancer. 2015 Feb 1;121(3):423-31. doi: 10.1002/cncr.29066. Epub 2014 Sep 23.

引用本文的文献

1

Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades.≥50岁经典型霍奇金淋巴瘤患者的治疗反应、毒性及生存情况：一项单中心二十年经验

Cancer Manag Res. 2022 Jun 7;14:1911-1921. doi: 10.2147/CMAR.S363235. eCollection 2022.